University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Kieuhoa Tran Vo, MD, MAS

Kieuhoa Tran Vo, MD, MAS

Assistant Professor, Department of Pediatrics, UCSF Benioff Children’s Hospital

Cancer Center Program Memberships

Pediatric Malignancies

Research Summary

My research career is focused on the development of novel prognostic and predictive biomarkers and incorporation of these biomarkers into new clinical trials, working towards more effective and less toxic therapies in children and young adults with solid tumors.

Education

University of Notre Dame, Notre Dame, IN B.S. 2000-2004 Biological Sciences, Minor in Anthropology
Indiana University School of Medicine, Indianapolis, IN M.D. 2004-2008 Medicine
Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH Residency 2008-2011 Pediatrics
UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA Fellowship 2012-2015 Pediatric Hematology/Oncology
University of California, San Francisco, Department of Epidemiology and Biostatistics M.A.S. 2013-2015 Clinical Research


Professional Experience

  • 2008-2009
    Internship, Pediatrics, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2009-2011
    Medical Residency, Pediatrics, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2012-2015
    Clinical Fellow, Division of Pediatric Hematology/Oncology, UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA
  • 2011-2012
    Clinical Assistant Professor, Department of Emergency Medicine, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2015-present
    Assistant Professor, Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA

Honors & Awards

  • 2008
    Indiana University School of Medicine Tina Kwan Scholarship Award in Pediatrics
  • 2013-present
    Developmental Therapeutics Scholar, Alex’s Lemonade Stand Foundation Center of Excellence Grant

Selected Publications

  1. Kieuhoa T. Vo, D. Williams Parsons, Nita L. Seibel. Precision Medicine in Pediatric Oncology. . 2019 Oct 1.
    View on PubMed
  2. David S. Shulman, Kieuhoa T. Vo, Elizabeth Fox, Jodi A. Muscal, Loren D. Walensky, Yana Pikman, Kimberly Stegmaier, Alanna Church, Brian D. Crompton, Andrew E. Place, Susan N. Chi, Allison F. O'Neill, Junne Kamihara, Suzanne Ezrre, Cecilia Carlowicz, Dawn Pinchasik, Hasan Al-Sayegh, Clement Ma, Wendy B. London, Steven G. DuBois. Abstract CT112: A Phase I multicenter trial of the dual MDM2/MDMX inhibitor ALRN-6924 in children and young adults with relapsed/refractory pediatric cancers. . 2019 Jul 1; ct112-ct112.
    View on PubMed
  3. Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biol Blood Marrow Transplant. 2019 Oct; 25(10):2031-2039.
    View on PubMed
  4. Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT. Med Phys. 2019 May; 46(5):2477-2486.
    View on PubMed
  5. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621.
    View on PubMed
  6. Kieuhoa Tran Vo, Jennifer Gibney Michlitsch, Avanthi T Shah, Janel Long-Boyle, Mi-Ok Kim, Clay Gustafson, Alejandro Sweet-Cordero, Katherine K. Matthay, Steven G. DuBois. Phase 1 multicenter trial to assess the maximum tolerated dose, safety, pharmacokinetics, and pharmacodynamics of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma. . 2018 May 20; 36(15_suppl):tps10576-tps10576.
    View on PubMed
  7. David Stephen Shulman, Cecilia Carlowicz, Clay Gustafson, Kieuhoa Tran Vo, Elizabeth Fox, Jodi Ann Muscal, Jeffrey G. Supko, Andrew E. Place, Susan N. Chi, Suzanne Shusterman, Gina Hanna, Jane O'Brien, Suzanne Ezrre, Pei-Chi Kao, Wendy B. London, Steven G. DuBois. Phase I multicenter trial of CUDC-907 in children and young adults with relapsed/refractory solid tumors, CNS tumors, and lymphomas. . 2018 May 20; 36(15_suppl):10542-10542.
    View on PubMed
  8. David Stephen Shulman, Clay Gustafson, Kieuhoa Tran Vo, Elizabeth Fox, Jodi Ann Muscal, Jeffrey G. Supko, Andrew E. Place, Susan N. Chi, Suzanne Shusterman, Gina Hanna, Jane O'Brien, Suzanne Ezrre, Cecilia Carlowicz, Wendy B. London, Steven G. DuBois. Phase 1 multicenter trial of CUDC-907 in children and young adults with relapsed or refractory solid tumors, CNS tumors, and lymphoma. . 2017 May 20; 35(15_suppl):tps10576-tps10576.
    View on PubMed
  9. Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2017 Apr 04; 8(14):23851-23861.
    View on PubMed
  10. Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 10; 66:144-52.
    View on PubMed
  11. Vo KT, Matthay KK, DuBois SG. Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9.
    View on PubMed
  12. Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5.
    View on PubMed
  13. Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 07 15; 22(14):3643-50.
    View on PubMed
  14. Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45.
    View on PubMed
  15. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 01; 32(28):3169-76.
    View on PubMed
  16. Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5.
    View on PubMed

Go to UCSF Profiles, powered by CTSI